India to Brazil: Ertapenem Export Trade Route
India has recorded 32 verified shipments of Ertapenem exported to Brazil, representing a combined trade value of $4.9M USD. This corridor is served by 2 active Indian exporters, with an average shipment value of $152.5K USD. The leading Indian exporter is EUGIA PHARMA SPECIALITIES LIMITED, which accounts for 76% of total export value with 25 shipments worth $3.7M USD. On the buying side, EUGIA PHARMA INDUSTRIA FARMACEUTICA is the largest importer in Brazil with $2.8M USD in purchases. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Brazil Ertapenem corridor is one of India's established pharmaceutical export routes, with 32 shipments documented worth a combined $4.9M USD. The route is dominated by EUGIA PHARMA SPECIALITIES LIMITED, which alone accounts for roughly 76% of all export value, reflecting the consolidated nature of India's ertapenem manufacturing sector.
Across 2 active suppliers, the average shipment value stands at $152.5K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 78% of all shipments, consistent with ertapenem's non-urgent bulk-order profile.
Shipment activity peaks during April–June, with an average transit time of 16 days port-to-port. The route has recorded an annual growth rate of 25.6%, placing it at rank #11 among India's top ertapenem export destinations globally.
On the import side, key buyers of Indian ertapenem in Brazil include EUGIA PHARMA INDUSTRIA FARMACEUTICA, AUROBINDO PHARMA INDUSTRIA , EUGIA PHARMA INDUSTRIA FARMACEUTICA LIMITED and 5 others. EUGIA PHARMA INDUSTRIA FARMACEUTICA is the single largest importer with 19 shipments valued at $2.8M USD.
Route Characteristics
- Average transit16 days
- Peak seasonQ2
- Primary modeSea freight
- Top portDELHI AIR CARGO ACC (INDEL4)
Market Position
- Global rank#11
- Annual growth+25.6%
- Demand growth+23.4%
- Regulatory ease81/100
Top 10 Indian Ertapenem Exporters to Brazil
Showing top 10 of 2 Indian suppliers exporting Ertapenem to Brazil, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | EUGIA PHARMA SPECIALITIES LIMITED Avg $147.4K per shipment | 25 | $3.7M | 75.5% |
| 2 | EUGIA PHARMA SPECIALITIES LIMITED Avg $170.6K per shipment | 7 | $1.2M | 24.5% |
This table shows the top 10 of 2 Indian companies exporting ertapenem to Brazil, ranked by total trade value. The listed exporters are: EUGIA PHARMA SPECIALITIES LIMITED, EUGIA PHARMA SPECIALITIES LIMITED . EUGIA PHARMA SPECIALITIES LIMITED is the dominant supplier with 25 shipments worth $3.7M USD, giving it a 76% market share.
Top 10 Ertapenem Importers in Brazil
Showing top 10 of 8 known buyers in Brazil receiving Ertapenem shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian ertapenem in Brazil include EUGIA PHARMA INDUSTRIA FARMACEUTICA, AUROBINDO PHARMA INDUSTRIA , EUGIA PHARMA INDUSTRIA FARMACEUTICA LIMITED, EUGIA PHARMA INDUSTRIA FARMACEUTICA , AUROBINDO PHARMA INDUSTRIA FARMACEU , among 8 total buyers. The largest importer is EUGIA PHARMA INDUSTRIA FARMACEUTICA, accounting for $2.8M USD across 19 shipments — representing 57% of all ertapenem imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | EUGIA PHARMA INDUSTRIA FARMACEUTICA | 19 | $2.8M | 56.9% |
| 2 | AUROBINDO PHARMA INDUSTRIA | 4 | $706.1K | 14.5% |
| 3 | EUGIA PHARMA INDUSTRIA FARMACEUTICA LIMITED | 3 | $455.0K | 9.3% |
| 4 | EUGIA PHARMA INDUSTRIA FARMACEUTICA | 2 | $301.5K | 6.2% |
| 5 | AUROBINDO PHARMA INDUSTRIA FARMACEU | 1 | $186.9K | 3.8% |
| 6 | AUROBINDO PHARMA INDUSTRIA FARMACEUTICA LTD | 1 | $151.4K | 3.1% |
| 7 | EUGIA PHARMA INDUSTRIA FARMACEUTICA LTD | 1 | $151.4K | 3.1% |
| 8 | AUROBINDO PHARMA INDUSTRIA FARMA | 1 | $149.2K | 3.1% |
Top 10 Ertapenem Formulations Imported by Brazil
Showing top 10 of 26 product formulations shipped on the India to Brazil Ertapenem route, ranked by trade value
Brazil imports a wide range of ertapenem formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — ERTAPENEM FOR INJECTION 1 G/VIAL (ERTAPE — accounts for $706.1K USD across 4 shipments. There are 26 distinct product descriptions in the dataset, reflecting the variety of dosage forms and strengths imported.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | ERTAPENEM FOR INJECTION 1 G/VIAL (ERTAPE | 4 | $706.1K | 14.5% |
| 2 | ERTAPENEM FOR INJECTION 1 G/VIAL (ERTAPE | 3 | $450.8K | 9.2% |
| 3 | ERTAPENEM FOR INJECTION 1 G/VIAL(Ertapen | 2 | $301.5K | 6.2% |
| 4 | ERTAPENEM FOR INJECTION 1 G/VIAL (ERATAP | 1 | $186.9K | 3.8% |
| 5 | ERTAPENEM FOR INJECTION 1 G VIAL ERTAPENEM FOR INJECTION 1G B N 2EI23025A MFG DT 02 2023 EXP DT 01 2025 | 1 | $166.3K | 3.4% |
| 6 | ERTAPENEM FOR INJECTION 1 G/VIALErtapenem for Injection 1g BT#2EI23189A MANUFACTURING DT-10/2023EXP DT- 09/2025 | 1 | $151.9K | 3.1% |
| 7 | ERTAPENEM FOR INJECTION 1 G/VIALErtapenem for Injection 1g BT#2EI23190A MANUFACTURING DT-10/2023EXP DT- 09/2025 | 1 | $151.9K | 3.1% |
| 8 | ERTAPENEM FOR INJECTION 1 G/VIALErtapenem for Injection 1g, BT#2EI23139A, MANUFACTURING DT- 08/2023,EXP DT-07/2025 | 1 | $151.4K | 3.1% |
| 9 | ERTAPENEM FOR INJECTION 1 G/VIALErtapenem for Injection 1g, BT#2EI23138A, MANUFACTURING DT-07/2023,EXP DT- 06/2025 | 1 | $151.4K | 3.1% |
| 10 | ERTAPENEM FOR INJECTION 1 G/VIALErtapenem for Injection 1g BT#2EI23191A MANUFACTURING DT-10/2023EXP DT- 09/2025 | 1 | $151.2K | 3.1% |
Showing top 10 of 26 Ertapenem formulations imported by Brazil on this route.
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Sea freight dominates at 78%, typical for bulk pharmaceutical shipments.
Top Ports of Origin
DELHI AIR CARGO ACC (INDEL4) handles the highest volume with 16 shipments. Transit time averages 16 days by sea.
Market Dynamics
India's ertapenem exports to Brazil are driven primarily by a handful of large-scale manufacturers. EUGIA PHARMA SPECIALITIES LIMITED with 25 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 2 active exporters signals a competitive but concentrated market — buyers in Brazil benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — EUGIA PHARMA SPECIALITIES LIMITED, EUGIA PHARMA SPECIALITIES LIMITED — together account for 100% of total trade value on this route. The average shipment value of $152.5K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.
Beyond the primary product category, shipments on this route include closely related formulations such as ertapenem for injection 1 g/vial (ertape and ertapenem for injection 1 g/vial(ertapen , suggesting that buyers in Brazil tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, EUGIA PHARMA INDUSTRIA FARMACEUTICA is the largest importer with 19 shipments worth $2.8M USD — representing 57% of all ertapenem imports from India on this route. A total of 8 buyers are active on this corridor.
Route Statistics
- Trade Volume
- $4.9M
- Avg. Shipment
- $152.5K
- Suppliers
- 2
- Buyers
- 8
- Transit (Sea)
- ~16 days
- Annual Growth
- +25.6%
Other Ertapenem Routes
Unlock the Full India to Brazil Ertapenem Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 32 shipments on this route.
Frequently Asked Questions — India to Brazil Ertapenem Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Ertapenem to Brazil?
The leading Indian exporters of Ertapenem to Brazil are EUGIA PHARMA SPECIALITIES LIMITED, EUGIA PHARMA SPECIALITIES LIMITED . EUGIA PHARMA SPECIALITIES LIMITED holds the largest market share at approximately 76% of total trade value on this route.
Q What is the total value of Ertapenem exports from India to Brazil?
India exports Ertapenem to Brazil worth approximately $4.9M USD across 32 recorded shipments. The average value per shipment is $152.5K USD.
Q Which ports does India use to ship Ertapenem to Brazil?
The most active port of origin is DELHI AIR CARGO ACC (INDEL4) with 16 shipments. Indian exporters primarily use sea freight for this route, with 78% of shipments going by sea and 24% by air.
Q How long does shipping take from India to Brazil for Ertapenem?
The average transit time for Ertapenem shipments from India to Brazil is approximately 16 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during April–June.
Q Is the India to Brazil Ertapenem trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 25.6% with demand growth tracking at 23.4%. The route is ranked #11 among India's top Ertapenem export destinations globally.
Q How many suppliers are active on the India to Brazil Ertapenem route?
There are currently 2 active Indian suppliers exporting Ertapenem to Brazil. The market is moderately concentrated with EUGIA PHARMA SPECIALITIES LIMITED accounting for 76% of total shipment value.
Q Who are the main importers of Ertapenem from India in Brazil?
The leading importers of Indian Ertapenem in Brazil include EUGIA PHARMA INDUSTRIA FARMACEUTICA, AUROBINDO PHARMA INDUSTRIA , EUGIA PHARMA INDUSTRIA FARMACEUTICA LIMITED, EUGIA PHARMA INDUSTRIA FARMACEUTICA , AUROBINDO PHARMA INDUSTRIA FARMACEU . EUGIA PHARMA INDUSTRIA FARMACEUTICA is the largest buyer with 19 shipments worth $2.8M USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to Brazil export trade corridor identified from Indian Customs (DGFT) records for Ertapenem.
- 2.Supplier/Buyer Matching: 2 Indian exporters and 8 importers in Brazil matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 32 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
32 Verified Shipments
2 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists